Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymph node surgery in papillary thyroid carcinoma.

Ernst Gemsenjäger1, Aurel Perren, Burkhardt Seifert

  • 1Surgical Clinic, Spital Zollikerberg, Zurich, Switzerland.

Journal of the American College of Surgeons
|August 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3D radiomics profiling of thyroid tumors using micro-CT.

Scientific reports·2026
Same author

[Hereditary neuroendocrine neoplasms].

Pathologie (Heidelberg, Germany)·2026
Same author

Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage.

British journal of cancer·2026
Same author

RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

MetAssist 2.0: A Generalizable Artificial Intelligence Framework for Lymph Node Metastasis Detection Across Multiple Cancer Types.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours.

Journal of neuroendocrinology·2026
Same journal

Breaking the Polytrauma-Brain Barrier: Using Point-of-Care Biomarkers in Severely Injured Trauma Patients.

Journal of the American College of Surgeons·2026
Same journal

Going the Extra Mile: Picking the Right Trauma Center Destination for Critically Injured Patients in a Mature State-Wide Trauma System.

Journal of the American College of Surgeons·2026
Same journal

What Does It Mean for Surgeons to Be Flourishing?

Journal of the American College of Surgeons·2026
Same journal

Tailor-Made Solution to Trimming Venous Thromboembolism Risk.

Journal of the American College of Surgeons·2026
Same journal

NIH Funding in Surgical Artificial Intelligence: Who, What, Where, Why.

Journal of the American College of Surgeons·2026
Same journal

Efficacy and Safety of Rezūm Water Vapor Thermal Ablation in Large and Small Prostates: A Multicenter Comparative Analysis of 2,725 Patients.

Journal of the American College of Surgeons·2026
See all related articles

Nodal disease in papillary thyroid carcinoma (PTC) is controversial. Occult nodal disease is uncommon and rarely progresses, suggesting clinical nodal status is reliable for guiding lymph node dissection extent.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Endocrine Surgery

Background:

  • The prognostic significance of lymph node metastasis in papillary thyroid carcinoma (PTC) is debated.
  • Accurate staging and appropriate surgical management of nodal disease are critical for patient outcomes.

Purpose of the Study:

  • To retrospectively analyze the impact of nodal disease on PTC patient outcomes.
  • To evaluate the role of clinical nodal staging in guiding lymphadenectomy decisions.
  • To investigate the incidence and progression of occult and metachronous nodal disease.

Main Methods:

  • Retrospective analysis of 159 PTC patients treated by a single surgeon over 1-27 years.
  • Evaluation of occult nodal disease, including metachronous metastasis (mpN(1)) in node-negative patients (pN(0), cN(0)).

Related Experiment Videos

  • Comparison of outcomes based on therapeutic, prophylactic, or no lymphadenectomy, and pathological nodal status (pN(1) vs. pN(0)).

    • Main Results:

    • Nodal recurrence occurred in 5% of patients, with higher rates in pN(1) (12%) versus pN(0) cN(0) (3%) and TNM high-risk (15%) versus low-risk (3%) patients.
    • In high-risk PTC, tumor-related survival was significantly lower for pN(1) (50%) compared to pN(0) cN(0) (86%).
    • Clinical staging sensitivity was 85% and specificity 99%; immunohistochemistry upstaged only 3% of nodes.

    Conclusions:

    • Occult nodal disease in PTC appears infrequent and has a low risk of progression to clinically recurrent disease.
    • Clinical nodal status is a reliable indicator for determining the extent of lymph node dissection.
    • Prophylactic central lymphadenectomy can be performed without significant morbidity; macroscopic nodal disease requires compartment-oriented dissection.